Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Raoof

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Gastroenterology|April 10, 2025
Therapeutic Targeting of Oncogene-induced Transcription-Replication Conflicts in Pancreatic Ductal AdenocarcinomaShanna J Smith, Fan Meng, Robert G Lingeman, et al.
The Journal of Surgical Research|October 8, 2023
Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal ChemotherapyIsabella Florissi, Shannon N Radomski, Benjamin Shou, et al.
Pleura and Peritoneum|December 23, 2022
Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and designMustafa Raoof, Kevin M Sullivan, Paul H Frankel, et al.
Frontiers in Oncology|August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Plos One|August 27, 2015
A New Imaging Platform for Visualizing Biological Effects of Non-Invasive Radiofrequency Electric-Field Cancer HyperthermiaStuart J Corr, Sabeel Shamsudeen, Leoncio A Vergara, et al.
Annals of Surgical Oncology|July 27, 2023
Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USAMustafa Raoof, Richard L Whelan, Kevin M Sullivan, et al.
Journal of Surgical Oncology|December 5, 2022
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPECBoateng Kubi, Richard Nudotor, Nadege Fackche, et al.
Annals of Surgical Oncology|May 8, 2020
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPECMichael K Turgeon, Adriana C Gamboa, Rachel M Lee, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Gastroenterology|April 10, 2025
Therapeutic Targeting of Oncogene-induced Transcription-Replication Conflicts in Pancreatic Ductal AdenocarcinomaShanna J Smith, Fan Meng, Robert G Lingeman, et al.
The Journal of Surgical Research|October 8, 2023
Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal ChemotherapyIsabella Florissi, Shannon N Radomski, Benjamin Shou, et al.
Pleura and Peritoneum|December 23, 2022
Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and designMustafa Raoof, Kevin M Sullivan, Paul H Frankel, et al.
Frontiers in Oncology|August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Plos One|August 27, 2015
A New Imaging Platform for Visualizing Biological Effects of Non-Invasive Radiofrequency Electric-Field Cancer HyperthermiaStuart J Corr, Sabeel Shamsudeen, Leoncio A Vergara, et al.
Annals of Surgical Oncology|July 27, 2023
Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USAMustafa Raoof, Richard L Whelan, Kevin M Sullivan, et al.
Journal of Surgical Oncology|December 5, 2022
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPECBoateng Kubi, Richard Nudotor, Nadege Fackche, et al.
Annals of Surgical Oncology|May 8, 2020
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPECMichael K Turgeon, Adriana C Gamboa, Rachel M Lee, et al.
Pageof 17